It is with great pleasure that the Personalised Medicine Network announces that the 3rd International Moesgaard Conference will be held in Aarhus on 5…
Side 11 af 11
The macrophage activation marker soluble CD163 as a biomarker of nonalcoholic fatty liver disease
Perspectives on treatment and outcome of chronic periprosthetic hip joint infection
Cognitive behavioural therapy for lumbar spinal fusion patients. A clinical and economic evaluation
Side 446 af 489